comparemela.com
  1. Home
  2. Live Updates
  3. Agile Therapeutics Fourth Quarter - Breaking News

Agile Therapeutics Fourth Quarter News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Agile Therapeutics, Inc (NASDAQ:AGRX) Q4 2023 Earnings Call Transcript

Agile Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-1.46 EPS, expectations were $-0.92.

Matt rileyAl altomariAgile therapeutics incAgile therapeuticsCall transcript marchAgile therapeutics fourth quarterFull yearResults conferenceInvestor relationsAgile therapeutic chairChief executiveInsiders are dumping theseTwirla januaryAffordable care

Agile Therapeutics, Inc (NASDAQ:AGRX) Q4 2022 Earnings Call Transcript

Operator: Good afternoon and welcome to the Agile Therapeutics Fourth Quarter and Full Year 2022 Financial Results Conference Call. Please note, today s event is being recorded.

United statesAmy welshOren livnatMatt rileyJason butchAl altomariHealth photoNational cancer institute on unsplashAgile therapeutics incAgile therapeuticsCall transcript marchAgile therapeutics fourth quarterFull yearResults conferenceInvestor relationsAgile therapeutic chairman

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.